About Stallion Laboratories Pvt Ltd
Data last updated:
Stallion Laboratories Pvt Ltd is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1988PTC010285. Its GSTIN is 24AACCS6205N1ZA (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹2.53 Cr. It is led by directors including Arvindkumar Jayantilal Thakker and Vijay Jasvantlal Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 8th Floor Dev Pathcuroad Navrangpura, Ahmedabad, Gujarat, India – 380006.
As per the financials filed for FY 2024, the company reported a revenue of ₹234.32 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹23.81 Cr (net margin 10.2%) and EBITDA of ₹45.9 Cr (EBITDA margin 19.6%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 16% over five years.
The company has about 229 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Stallion Laboratories. As per MCA filings, the company has open charges of ₹95.64 Cr and satisfied charges of ₹1.65 Cr on record. Court records list 55 cases involving the company, including 31 filed by the company and 24 filed against it; 17 cases are pending. The company has 14 deals on record (8 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹2.55 Cr; the latest was in March 2023. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Healthcaps India Limited with revenue of ₹239.43 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,154 overdue payments to 63 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stallionlabs.com.
Company details
Contact details
Stallion Laboratories Pvt Ltd's registered office is in Ahmedabad, Gujarat. Its website is stallionlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address8th Floor Dev Pathcuroad Navrangpura, Ahmedabad, Gujarat, India – 380006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stallion Laboratories Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Stallion Laboratories operates one associated brand: Stallion Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Limited information available | stallionlabs.com |
Business activity
The main business activity of Stallion Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Stallion Laboratories Pvt Ltd, buy the company report.
Financials of Stallion Laboratories Pvt Ltd
FY 2024 filings availableStallion Laboratories Pvt Ltd reported revenue of ₹234.32 Cr (up 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 25% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹234.32 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹45.9 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23.81 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.6% | ||||
| Net Profit Margin | 10.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stallion Laboratories Pvt Ltd, buy the company report.
Board of directors of Stallion Laboratories Pvt Ltd
Stallion Laboratories has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvindkumar Jayantilal Thakker | Director | 25 Jun 2020 | 6 Years 4 Months | Current |
| Vijay Jasvantlal Shah | Director | 30 May 1990 | 36 Years 4 Months | Current |
| Vipulkumar Rajnikant Shah | Director | 30 May 1990 | 36 Years 4 Months | Current |
Peer comparison
Stallion Laboratories Pvt Ltd is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healthcaps India Limited | ₹239.43 Cr (FY 2025) | -2.0% | Fatehpur, Punjab, India | |||
| Kemwell Biopharma Private Limited | ₹239.14 Cr (FY 2025) | 10.0% | Bangalore, Karnataka, India | |||
| Laurus Synthesis Private Limited | ₹238.89 Cr (FY 2025) | 179.0% | Anakapalle, Andhra Pradesh, India | |||
| Stallion Laboratories Pvt Ltdthis company | ₹234.32 Cr (FY 2024) | ₹23.81 Cr | 10.2% | 25.0% | 229 | Ahmedabad, Gujarat, India |
| Emil Pharmaceutical Industries Private Limited | ₹232.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Axa Parenterals Limited | ₹231.46 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Stallion Laboratories Pvt Ltd, buy the company report.
Auditor
Stallion Laboratories Pvt Ltd is audited by PARIMAL S. SHAH & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARIMAL S. SHAH & CO. | FY 2024 | 107591W |
Shareholding
The shareholding of Stallion Laboratories Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stallion Laboratories Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2025 | 101151260 | Others | ₹15.3 Lakh | Open | |
| 25 Jun 2025 | 101151396 | Others | ₹15.45 Lakh | Open | |
| 29 Mar 2025 | 101085545 | Others | ₹13.5 Lakh | Open | |
| 22 Jan 2024 | 100866216 | Hdfc Bank Limited | ₹14 Lakh | Open | |
| 02 Aug 2023 | 100774322 | Hdfc Bank Limited | ₹50.06 Lakh | Open |
To see the full charge records of Stallion Laboratories Pvt Ltd, buy the company report.
Total charge records: 25 View all charges
Deals & funding
Stallion Laboratories Pvt Ltd has 14 deals on record (8 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹2.55 Cr; the latest was in March 2023.
Deals on record (5 of 14)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jan 2019 | Rights issue | ₹5 Cr | Investors: 3 individuals |
| Oct 2013 | Funding round | ₹40 Lakh | Investors: 3 individuals |
To see the full deal history of Stallion Laboratories Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Stallion Laboratories Pvt Ltd has 55 court cases on record: 31 filed by Stallion Laboratories, 24 filed against it. 17 cases are pending and 38 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 34 | 19 | 11 |
| High courts | 21 | 5 | 6 |
Cases on record (5 of 55)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Special civil application | Filed by the company against Gujarat Medical Services Corporation Limited | Pending |
| High Court of Gujarat | Special civil application | Filed by the company against Gujarat Medical Services Corporation Limited | Pending |
| District court, Ahmedabad, Gujarat | Court case (CS CCC) | Filed by the company against Rhythm Biotech Private Ltd. | Pending |
| High Court, GUJARAT | Court case (AO) | Filed by the company against Rhythm Biotech Private Ltd | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by La Renon Healthcare Private Limited Through Its Authorised Representative Vrajesh Chokshi | Pending |
To see the full case history of Stallion Laboratories Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Stallion Laboratories Pvt Ltd was last rated by Icra on 22 Nov 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 22 Nov 2021 |
To see the full credit ratings and regulatory alerts of Stallion Laboratories Pvt Ltd, buy the company report.
MSME payment delays
Stallion Laboratories Pvt Ltd has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,154 overdue payments to 63 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 63)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Nikvin Healthcare (India) Private Limited | |||
| Talent Healthcare | |||
| Online Print and Pack Private Limited | |||
| Vishal Enterprise | |||
| Halogens |
To see the full MSME payment records of Stallion Laboratories Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Stallion Laboratories Pvt Ltd has a workforce of 229 employees on its EPFO records as of Mar 27, 2025, across 1 active EPFO establishment.
GST
Stallion Laboratories has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCS6205N1ZA | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stallion Laboratories Pvt Ltd, buy the company report.
Recent activity
Stallion Laboratories Pvt Ltd has 8 board changes on record since 1990: 3 appointments and 5 cessations. The latest: Arvindkumar Jayantilal Thakker was appointed as Director on 25 Jun 2020.
37 earlier events are in the company report.
Frequently asked questions
Stallion Laboratories is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 1988 (38+ years old) and is registered under CIN U24231GJ1988PTC010285.
Stallion Laboratories has 3 current directors:
- Arvindkumar Jayantilal Thakker - Director
- Vijay Jasvantlal Shah - Director
- Vipulkumar Rajnikant Shah - Director
The latest financial statements of Stallion Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Stallion Laboratories is 24AACCS6205N1ZA, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Stallion Laboratories is U24231GJ1988PTC010285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stallion Laboratories has 55 court cases on record: 31 filed by the company and 24 filed against it. 17 are pending. Most are in the district courts.
Stallion Laboratories was incorporated on 18 January 1988, making it 38+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Stallion Laboratories has 14 deals on record (8 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹2.55 Cr; the latest was in March 2023.
The peers of Stallion Laboratories by revenue are Healthcaps India Limited, Kemwell Biopharma Private Limited, Laurus Synthesis Private Limited, Emil Pharmaceutical Industries Private Limited, Axa Parenterals Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arvindkumar Jayantilal Thakker was appointed as Director on 25 Jun 2020. Apurva Sudhir Shah ceased to be Director on 01 Jun 2017. Sharad Bhogilal Shah ceased to be Director on 01 Sep 2012. Stallion Laboratories has 8 board changes on record in total.
Stallion Laboratories has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,154 overdue payments to 63 micro and small suppliers. The latest return was filed on 23 Jun 2024.
Stallion Laboratories can be reached through the website stallionlabs.com. Its registered office is in Ahmedabad, Gujarat, India.